BR112015030090A2 - preparações sólidas contendo extratos de pelargonium sidoides e um composto de ácido silícico bem como método para a sua preparação - Google Patents

preparações sólidas contendo extratos de pelargonium sidoides e um composto de ácido silícico bem como método para a sua preparação

Info

Publication number
BR112015030090A2
BR112015030090A2 BR112015030090A BR112015030090A BR112015030090A2 BR 112015030090 A2 BR112015030090 A2 BR 112015030090A2 BR 112015030090 A BR112015030090 A BR 112015030090A BR 112015030090 A BR112015030090 A BR 112015030090A BR 112015030090 A2 BR112015030090 A2 BR 112015030090A2
Authority
BR
Brazil
Prior art keywords
preparation
acid compound
silicic acid
pelargonium sidoides
solid
Prior art date
Application number
BR112015030090A
Other languages
English (en)
Other versions
BR112015030090B1 (pt
Inventor
Gu Min Byung
Hoon Lee Byung
Hyoung Ki Do
Gyu Lee Dong
Joon Jun Hyung
Hyun Ahn Ji
Seong Chung Jin
Yeol Nam Kyu
Min Cho Sang
Tae Jung Won
Woong Choi Youn
Original Assignee
Korea United Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53025925&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015030090(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Korea United Pharm Inc filed Critical Korea United Pharm Inc
Publication of BR112015030090A2 publication Critical patent/BR112015030090A2/pt
Publication of BR112015030090B1 publication Critical patent/BR112015030090B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

resumo da patente de invenção para: preparações sólidas contendo extratos de pelargonium sidoides e um composto de ácido silícico bem como método para a sua preparação”. a presente invenção refere-se a uma preparação sólida de um extrato de pelargonium sidoides e um composto de ácido silícico, que pode ser formulada na forma sólida por adsorção direta do extrato de pelargonium sidoides num composto de ácido silícico, e refere-se igualmente a um método para a sua preparação. uma vez que a preparação sólida do extrato de pelargonium sidoides e do composto de ácido da presente invenção tem maior estabilidade do que uma preparação líquida, tal como xarope, e não tem aditivos, tais como açúcares, não há qualquer problema de contaminação microbiana ou degradação da preparação. é também possível embalar a preparação sólida individualmente. uma vez que a preparação sólida representa um volume mais pequeno do que a preparação líquida, é facilmente transportável e tem também a vantagem de não necessitar de utensílios como colher, copo, etc., para a sua ingestão. além disso, o princípio ativo pode ser tomado todas as vezes numa quantidade igual.
BR112015030090-1A 2013-12-20 2014-12-19 Preparações sólidas contendo extratos de pelargonium sidoides e um composto de ácido silícico bem como método para a sua preparação BR112015030090B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20130159980A KR101497508B1 (ko) 2013-12-20 2013-12-20 펠라고니움 시도이데스 추출물 및 규산 화합물을 포함하는 고형 제제 및 이의 제조 방법
KR10-2013-0159980 2013-12-20
PCT/KR2014/012592 WO2015093899A1 (en) 2013-12-20 2014-12-19 Solid preparations containing pelargonium sidoides extracts and silicic acid compound, and preparing method thereof

Publications (2)

Publication Number Publication Date
BR112015030090A2 true BR112015030090A2 (pt) 2017-07-25
BR112015030090B1 BR112015030090B1 (pt) 2023-02-14

Family

ID=53025925

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015030090-1A BR112015030090B1 (pt) 2013-12-20 2014-12-19 Preparações sólidas contendo extratos de pelargonium sidoides e um composto de ácido silícico bem como método para a sua preparação

Country Status (10)

Country Link
US (1) US20160287651A1 (pt)
EP (1) EP3082774A4 (pt)
KR (1) KR101497508B1 (pt)
CN (1) CN105246465B (pt)
BR (1) BR112015030090B1 (pt)
HK (1) HK1215669A1 (pt)
MX (2) MX2015016942A (pt)
PH (1) PH12015502499A1 (pt)
RU (1) RU2612085C1 (pt)
WO (1) WO2015093899A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800002457A1 (it) * 2018-02-07 2019-08-07 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie
KR20200004178A (ko) 2018-07-03 2020-01-13 한국유나이티드제약 주식회사 펠라고니움 시도이데스 추출물을 포함하는 약학 조성물 및 이의 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
KR100210106B1 (ko) * 1997-06-02 1999-07-15 윤종용 냉장고의 급수호스 고정장치
DE102004032439A1 (de) * 2004-07-05 2006-02-02 Iso Arzneimittel Gmbh & Co Kg Verwendung von Extrakten aus Wurzeln von Pelargonium sidoides und Pelargonium reniforme
CN101384281A (zh) * 2006-02-20 2009-03-11 朝日啤酒株式会社 颗粒、片剂以及它们的制备方法
DE102006032326A1 (de) * 2006-07-12 2008-01-17 Dr. Willmar Schwabe Gmbh & Co. Kg Verwendung von Extrakten aus Pelargonium sidoides und/oder Pelargonium reniforme sowie diese Extrakte enthaltende Mittel und pharmazeutische Formulierungen
RU2474432C2 (ru) * 2007-04-17 2013-02-10 Др. Вилльмар Швабе Гмбх Унд Ко. Кг СПОСОБ ПОЛУЧЕНИЯ ЭКСТРАКТА ИЗ Pelargonium sidoides И Pelargonium reniforme
CN101801348A (zh) * 2007-06-22 2010-08-11 百时美施贵宝公司 含有阿扎那韦的压片组合物
CN103041768A (zh) * 2013-01-09 2013-04-17 内蒙古科技大学 一种改性硅酸钙吸附剂的制备方法

Also Published As

Publication number Publication date
PH12015502499B1 (en) 2016-02-22
KR101497508B1 (ko) 2015-03-03
WO2015093899A1 (en) 2015-06-25
CN105246465A (zh) 2016-01-13
EP3082774A4 (en) 2017-05-10
BR112015030090B1 (pt) 2023-02-14
CN105246465B (zh) 2018-01-30
EP3082774A1 (en) 2016-10-26
MX2020003134A (es) 2020-07-28
PH12015502499A1 (en) 2016-02-22
RU2612085C1 (ru) 2017-03-02
MX2015016942A (es) 2016-04-25
HK1215669A1 (zh) 2016-09-09
US20160287651A1 (en) 2016-10-06

Similar Documents

Publication Publication Date Title
BR112014009087A2 (pt) formulações de etanercept estabilizadas com xilitol
EA201791717A1 (ru) Стабильные водные составы адалимумаба
PH12014502778A1 (en) Antibody formulation
BR112015011843B8 (pt) composição para promover a saúde intestinal
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2017007178A (es) Formulaciones liquidas estables de virus de vacuna.
EA201892729A1 (ru) Гемисульфатная соль 5,10-метилен-(6r)-тетрагидрофолиевой кислоты
HRP20201242T1 (hr) Tekući farmaceutski pripravak
PE20142043A1 (es) Enfoque metabolico selectivo para aumentar la biodisponibilidad oral de la fenilefrina y otros bioactivos metabolicos
UA110979C2 (uk) Рідка фармацевтична композиція, яка включає нітизинон
EA201691244A1 (ru) Фармацевтическая композиция, содержащая соединение пиридиламиноуксусной кислоты
WO2014153009A3 (en) Thiosaccharide mucolytic agents
RS53783B1 (en) INHALATION MEDICINAL PRODUCTS INCLUDING TIOTROPIUM
EA201400535A1 (ru) Индивидуальная композиция для очищения
MX2015009617A (es) Formas cristalinas de acido { [1-ciano-5-(4-clorofenoxi)-4-hidroxi -isoquinolin-3-carbonil]-amino}-acetico.
WO2015076717A3 (en) Mscs in the treatment of cardiac disorders
BR112015030090A2 (pt) preparações sólidas contendo extratos de pelargonium sidoides e um composto de ácido silícico bem como método para a sua preparação
BR112017020053A2 (pt) novo composto heterocíclico, método para a preparação do mesmo e composição farmacêutica compreendendo o mesmo
EA201690692A1 (ru) Пищевая липидная композиция, содержащая стеаридоновую кислоту и оливковое масло
EA201690216A1 (ru) Фармацевтические композиции ранолазина и дронедарона
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same
PH12015502727A1 (en) Methods and compositions for enhancing cognitive performance
EA201690395A1 (ru) Стабильная фармацевтическая композиция, содержащая бисопролол и рамиприл
UA110822C2 (uk) Піперидинілмонокарбонові кислоти як агоністи s1p1-рецепторів
BR112017009743A2 (pt) produto de bebida com tartarato de sódio e potássio

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/12/2014, OBSERVADAS AS CONDICOES LEGAIS